Differential effect of fluoxetine on psychopathology of borderline personality disorders Efecto diferencial de fluoxetina en psicopatología de personalidad límite
Author
dc.contributor.author
Fierro Silva, Hernán Alejandro
Author
dc.contributor.author
Jerez, Sonia
Author
dc.contributor.author
Paredes, Angélica
Author
dc.contributor.author
Montes, Cristián
Author
dc.contributor.author
Rentería, Patricia
Author
dc.contributor.author
Ramírez, Alejandra
Author
dc.contributor.author
Salvo, Jezabel
Admission date
dc.date.accessioned
2019-01-29T17:57:13Z
Available date
dc.date.available
2019-01-29T17:57:13Z
Publication date
dc.date.issued
2003
Cita de ítem
dc.identifier.citation
Revista Chilena de Neuro-Psiquiatria, Volumen 41, Issue 4, 2018, Pages 271-279
Identifier
dc.identifier.issn
00347388
Identifier
dc.identifier.issn
07179227
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163962
Abstract
dc.description.abstract
Introduction. Depression and impulsivity has been associated to a dysfunction of serotonergic system and are treated with serotonin reuptake inhibitors (SSRI). In this work we study differential effects of fluoxetine on impulsivity and depressive symptoms in borderline personality disorders patients. Subjects and method. 38 borderline personality disorders patients without Axis I disorder were treated by seven weeks with flexible doses of fluoxetine. Patients were evaluated with BPRS, GAF, Hamilton Depression Rating Scale and an impulsivity scale. Temporal variations of symptomatology in high and low impulsive patients were compared. Results. Global symptomatology, depressive symptoms and impulsivity diminished. High impulsive patients present reduction in impulsivity in the first two weeks of treatment. Likewise, low impulsive patients had great reduction of depressive symptoms since the third week of treatment. Conclusions. Fluoxetine has a differential effect on impulsivity and depr
Differential effect of fluoxetine on psychopathology of borderline personality disorders Efecto diferencial de fluoxetina en psicopatología de personalidad límite